Showing results (31-40 of 118) with videos related to
Sort By:
Pageof 12
Pharmaceutical Research|January 26, 2008
Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteriaJunichi Kamiie, Sumio Ohtsuki, Ryo Iwase, et al.Hematology (Amsterdam, Netherlands)|January 19, 2017
CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemiaShin-Ichiro Fujiwara, Kazuo Muroi, Chihiro Yamamoto, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 7, 2025
Actual versus ideal donor body weight in planning bone marrow harvestRui Murahashi, Shin-Ichiro Fujiwara, Daisuke Minakata, et al.Leukemia & Lymphoma|May 24, 2013
Clinical features of de novo CD25-positive follicular lymphomaShin-ichiro Fujiwara, Kazuo Muroi, Raine Tatara, et al.Experimental Hematology|March 31, 2004
Ascorbic acid restores sensitivity to imatinib via suppression of Nrf2-dependent gene expression in the imatinib-resistant cell lineTakahisa Tarumoto, Tadashi Nagai, Ken Ohmine, et al.International Journal of Hematology|October 28, 2017
Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: long-term follow-up of the Japanese subgroup of the randomized ENESTnd trialHirohisa Nakamae, Tetsuya Fukuda, Chiaki Nakaseko, et al.British Journal of Haematology|July 26, 2002
DNA microarray analysis of T cell-type lymphoproliferative disease of granular lymphocytesHideki Makishima, Fumihiro Ishida, Toshiro Ito, et al.International Journal of Hematology|September 11, 2021
Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trialHirohisa Nakamae, Masahide Yamamoto, Emiko Sakaida, et al.Leukemia & Lymphoma|September 7, 2018
Prognostic impact of serum soluble interleukin-2 receptor level at diagnosis in elderly patients with diffuse large B-cell lymphoma treated with R-CHOPKento Umino, Shin-Ichiro Fujiwara, Daisuke Minakata, et al.International Journal of Hematology|October 27, 2010
Incidental carcinomas detected by PET/CT scans in patients with malignant lymphomaKazuya Sato, Katsutoshi Ozaki, Shin-ichiro Fujiwara, et al.Pageof 12